GENMAB A/S (GMAB) Executive Compensation | rentseek.ing

GENMAB A/S (GMAB)

Ask a question about this filing

Open in WorkspaceWorkspace

01FY? total compensation breakdown

How much does the CEO get paid?

Activity timeline · Latest filing

Grants, governance, and insider moves

Recent events from filings

GrantsBuysSalesGifts/plannedGovernance

Dec 29, 2025
A/s Genmab bought
$7359.1M • −75,867,199 shares • @$97.00
Dec 29, 2025
A/s Genmab bought
-$102.1M • +1,052,806 shares • @$97.00
Dec 26, 2025
A/s Genmab bought
-$288.9K • +2,978 shares • @$97.00
Dec 26, 2025
A/s Genmab bought
-$13.8M • +142,610 shares • @$97.00
Dec 24, 2025
A/s Genmab bought
-$9.3M • +96,082 shares • @$97.00
Dec 23, 2025
A/s Genmab bought
-$54.4M • +561,042 shares • @$97.00
Dec 22, 2025
A/s Genmab bought
-$1.5M • +15,710 shares • @$97.00
Dec 19, 2025
A/s Genmab bought
-$6.4M • +66,264 shares • @$97.00

Pay & Performance Snapshot

We need at least two years of pay and stock data to show the trend.

02Pay changes vs. stock performance

Is this pay justified?

03Recent insider trades by officers and directors

Are insiders buying or selling?

~9 trades

Showing rolling 12-month insider activity from the latest filing on record.

Company-wide activity · ~9 filingsPartial history

Conviction read

Are insiders selling into strength or holding through dips?

Run the conviction pass when you want the tape interpreted, not just listed.

Current lens

Company-wide activity

Insider transaction reports and planned sale notices for FY2024-FY2025. Showing FY2024-FY2025 insider trades across all insiders. Through 2026-02-17.

Company-wide activity recent activity

~9 filings captured for FY2024-FY2025

GENMAB A/S

Dec 29, 2025 · Purchase

Code PValue +$7,359,118,303

SEC filing →

GENMAB A/S

Dec 29, 2025 · Purchase

Code PValue −$102,122,182

SEC filing →

GENMAB A/S

Dec 26, 2025 · Purchase

Code PValue −$288,866

SEC filing →

GENMAB A/S

Dec 26, 2025 · Purchase

Code PValue −$13,833,170

SEC filing →

Filing log

Company-wide activity filing log

~9 filings captured for FY2024-FY2025.

FY2024–FY2025

Compare insider activity →

04Board composition and compensation for FY2025

Who sits on the board?

Board data for FY2025 is not yet available

This company is expected to file its proxy statement soon.

Board Pay Rankings →Start a Campaign →

05Take action on executive compensation

What can you do about it?

Shareholder activism tools

Start or join campaigns to engage with GMAB's board on executive compensation, governance, and shareholder proposals.

Activism Beta — Sign in to start or join campaigns

Start a Campaign for GMAB See Existing Campaigns

06For analysts and deep research

Full data tables

Show grant reconciliation, pay tables, and equity data

Loading expanded grant and equity tables…

Want to know when GENMAB A/S files their next proxy?

Get one email when new executive compensation data is filed and processed.

Compensation data unavailable

We could not find structured top executive compensation for this company yet. Try ingesting a more recent filing or verify the source data.

GENMAB A/S (GMAB)

Ask a question about this filing

Open in WorkspaceWorkspace

01FY? total compensation breakdown

How much does the CEO get paid?

Activity timeline · Latest filing

Grants, governance, and insider moves

Recent events from filings

GrantsBuysSalesGifts/plannedGovernance

Dec 29, 2025
A/s Genmab bought
$7359.1M • −75,867,199 shares • @$97.00
Dec 29, 2025
A/s Genmab bought
-$102.1M • +1,052,806 shares • @$97.00
Dec 26, 2025
A/s Genmab bought
-$288.9K • +2,978 shares • @$97.00
Dec 26, 2025
A/s Genmab bought
-$13.8M • +142,610 shares • @$97.00
Dec 24, 2025
A/s Genmab bought
-$9.3M • +96,082 shares • @$97.00
Dec 23, 2025
A/s Genmab bought
-$54.4M • +561,042 shares • @$97.00
Dec 22, 2025
A/s Genmab bought
-$1.5M • +15,710 shares • @$97.00
Dec 19, 2025
A/s Genmab bought
-$6.4M • +66,264 shares • @$97.00

Pay & Performance Snapshot

We need at least two years of pay and stock data to show the trend.

02Pay changes vs. stock performance

Is this pay justified?

03Recent insider trades by officers and directors

Are insiders buying or selling?

~9 trades

Showing rolling 12-month insider activity from the latest filing on record.

Company-wide activity · ~9 filingsPartial history

Conviction read

Are insiders selling into strength or holding through dips?

Run the conviction pass when you want the tape interpreted, not just listed.

Current lens

Company-wide activity

Insider transaction reports and planned sale notices for FY2024-FY2025. Showing FY2024-FY2025 insider trades across all insiders. Through 2026-02-17.

Company-wide activity recent activity

~9 filings captured for FY2024-FY2025

GENMAB A/S

Dec 29, 2025 · Purchase

Code PValue +$7,359,118,303

SEC filing →

GENMAB A/S

Dec 29, 2025 · Purchase

Code PValue −$102,122,182

SEC filing →

GENMAB A/S

Dec 26, 2025 · Purchase

Code PValue −$288,866

SEC filing →

GENMAB A/S

Dec 26, 2025 · Purchase

Code PValue −$13,833,170

SEC filing →

Filing log

Company-wide activity filing log

~9 filings captured for FY2024-FY2025.

FY2024–FY2025

Compare insider activity →

04Board composition and compensation for FY2025

Who sits on the board?

Board data for FY2025 is not yet available

This company is expected to file its proxy statement soon.

Board Pay Rankings →Start a Campaign →

05Take action on executive compensation

What can you do about it?

Shareholder activism tools

Start or join campaigns to engage with GMAB's board on executive compensation, governance, and shareholder proposals.

Activism Beta — Sign in to start or join campaigns

Start a Campaign for GMAB See Existing Campaigns

06For analysts and deep research

Full data tables

Show grant reconciliation, pay tables, and equity data

Loading expanded grant and equity tables…

Want to know when GENMAB A/S files their next proxy?

Get one email when new executive compensation data is filed and processed.

Compensation data unavailable

We could not find structured top executive compensation for this company yet. Try ingesting a more recent filing or verify the source data.